The interactions between RNA and biological macromolecules are clearly essential for many vital processes in molecular biology, and the excitement over RNA-based viruses has fueled an interest in the development of potential RNA inhibitors. Recently, a considerable amount of attention has been focused on new RNA-binding molecules for drug discovery. 1, 2, 3, 4, 5, 6 and 7 RNA offers several selective advantages over DNA as a therapeutic agent. First, ...